D-Wave, Quantum

D-Wave Quantum: A Government Sell-Down Looms as the Physics Gets Real

Published on 09/11/2026 at 11:51 | Editorial boerse-global.de

D-Wave registers 7.1M CHIPS Act shares for resale, posts a Q2 revenue miss, and sees its CFO resign, while Nature validates its gate tech.

D-Wave Quantum: CHIPS Act Shares Registered, Q2 Revenue Misses
D-Wave Quantum Illustration mit AI erstellt.

D-Wave Quantum has spent the past week generating headlines faster than its annealing systems can cool — a CHIPS Act windfall, a CFO exit, a peer-reviewed gate result in Nature. Strip away the noise, though, and the more consequential developments sit elsewhere: a completed acquisition that is quietly delivering operational substance, fresh commercial wins on two continents, and a share price that keeps drifting away from the fundamental story.

Washington's Exit Door Is Now Open

The most mechanical — and most easily misread — item came Thursday, when D-Wave filed a prospectus supplement with the US Securities and Exchange Commission permitting the Department of Commerce to resell 7,095,721 common shares. The filing, made under a Form S-3ASR registration and handled by law firm Paul, Weiss, carries no proceeds for D-Wave itself: no new stock is being issued, and no sale has taken place so far.

The stake traces back to the recently finalized CHIPS Act award, under which Washington committed up to $100 million to D-Wave in exchange for a minority position carrying no control rights. That news had already moved the stock a day earlier, leaving it up 0.9% since. Thursday's paperwork is simply the technical prerequisite — the shares must be registered before the government can liquidate them. No immediate selling pressure follows automatically, but investors should register that a potential overhang of roughly seven million shares now sits in the market, ready to move should the department decide to head for the exit.

Valuation Draws Fresh Scrutiny

Registration aside, D-Wave's price tag is back under the microscope. By Simply Wall St's tally, only one of six common valuation checks comes out positive. The price-to-book ratio stands near 5.9, against roughly 3.0 for the broader software sector — yet well below the roughly 11.8 commanded by comparable quantum computing rivals. CHIPS Act money may shore up the balance sheet, but ongoing investigations into earlier company statements add to the clouded picture. After a strong three-year run, many observers now consider the stock ambitiously valued.

The shares traded pre-market at EUR 14.54 following a Thursday close of EUR 14.41. That remains well under the 50-day average of EUR 16.21 and about 64% below the 52-week high of EUR 40.41 set last October. Against the recent annual low of EUR 11.12 touched at the end of March, there is still a 31% cushion to the upside.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

The Acquisition That Actually Matters

For all the attention on subsidies and filings, the more interesting thread runs through D-Wave's dual strategy: annealing quantum computers, which already generate revenue, and gate-model technology for the future. That second bet took on a new dimension with the January completion of the Quantum Circuits, Inc. acquisition — D-Wave now holds every outstanding share of the company.

The integration is long since done, but it has become relevant again because Wednesday's Nature paper — describing a two-qubit gate with roughly 99.9% fidelity and gate times of about 500 nanoseconds — lands squarely in that division. That, more than any balance-sheet headline, is the evidence that the takeover delivered operating substance rather than accounting fireworks.

Commercial Traction, Quiet but Steady

On the commercial side, progress continues without fanfare. Florida Atlantic University has committed $20 million to purchase and install an Advantage2 annealing system in Boca Raton, subject to the usual public-institution procurement rules in Florida. Meanwhile NTT DOCOMO — which D-Wave describes as Japan's largest mobile carrier, with more than 93 million connections — has rolled out a second D-Wave-powered application into live network operations. Two customers, two industries, two confirmations that D-Wave is outgrowing pure research status.

The Numbers That Resist Spin

Impressive as the technology narrative is, the business figures put a brake on the enthusiasm. Second-quarter 2026 revenue came in at $3.08 million, short of the $4.03 million expected. Regardless of the precise loss figure, that is a revenue miss that has to be taken seriously by anyone taking the growth story seriously. Anyone backing D-Wave must therefore hold two timelines in mind at once: the short one, where quarterly numbers can disappoint, and the long one, where grant money and technology breakthroughs are what count.

That is where the biggest risk sits, in my view. Chief Financial Officer John Markovich announced his resignation about a week ago, effective September 2 — a change at the finance helm precisely as the company administers grant funding, has issued shares to the US Department of Commerce, and must manage operational integration. Continuity in that seat would have been preferable.

What the Tape Is Saying

The stock trades at EUR 14.59, roughly 10% below its 50-day average of EUR 16.22 — a sign the market has yet to read the recent news barrage as a clear turning point. Year-to-date, the shares are down 36%, underscoring how far fundamental substance and price performance have diverged. Institutional investors appear to see it more selectively than the broader market: Legal & General Group acquired new D-Wave shares worth about $6.73 million in early September, a signal that at least part of the professional investor base is staying with the long-term story.

D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.

The Wider Funding Race

Competition for the subsidy pot remains fierce. Alongside D-Wave, both Rigetti and Quantinuum received up to $100 million each from the CHIPS Act, while GlobalFoundries secured as much as $375 million for its new Quantum Technology Solutions business. In total, nine quantum firms have been awarded just over $2 billion in support. The Motley Fool editorial team ties D-Wave's allocation in particular to supply chain and manufacturing scale-up, while Rigetti is focused on cooling technology and chip connectivity, and Quantinuum on US manufacturing partnerships.

At the same time, the case of NEC illustrates how uncertain quantum commercialization remains overall: the Japanese conglomerate halted its own quantum computer development, judging that further investment would have required more than a decade and that monetization looked too difficult. For D-Wave — which, unlike NEC, already sells commercial systems and now adds state backing on top — that contrast underscores its special position, but also the pressure investors are likely to apply when it comes to actually delivering on the grant money.

The Bottom Line

All told, D-Wave looks like a company delivering more on both technology and business than its share price currently reflects. The combination of Nature-validated gate technology, a growing customer base, and government funding argues for structural potential. Working against that thesis are the second-quarter revenue miss and the CFO transition — two drags investors should not ignore. For my money, the technological substance outweighs the near-term operational friction, though this stock's volatility is unlikely to cool in the months ahead.

Ad

D-Wave Quantum Stock: New Analysis - 11 September

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

Disclaimer...

en | US26740W1099 | D-WAVE | boerse | 70086697 |